1292250
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 6, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lenexa, KS (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)